CUE - Cue Biopharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Assets
Current assets
Cash
Cash and cash equivalents
44,290
20,800
63,534
14,926
Other short-term investments
15,120
18,413
50.068
50.033
Total cash
59,410
39,213
63,584
14,976
Net receivables
754.898
-
-
-
Total current assets
61,025
40,610
65,065
15,138
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
9,210
4,147
2,352
1,270
Accumulated depreciation
-2,026
-1,366
-661.153
-246.9
Net property, plant and equipment
7,184
2,781
1,691
1,023
Intangible assets
-
-
175
-
Other long-term assets
823.625
958.729
23.282
-
Total non-current assets
10,580
4,753
1,889
1,140
Total assets
71,605
45,363
66,954
16,279
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
2,500
-
Accounts payable
882.666
2,035
-
-
Accrued liabilities
651.531
592.313
-
-
Deferred revenues
4,097
2,012
623.853
-
Total current liabilities
11,655
6,217
5,347
1,068
Non-current liabilities
Deferred revenues
4,018
5,175
-
-
Total non-current liabilities
5,366
5,175
0
36.364
Total liabilities
17,021
11,392
5,347
1,104
Stockholders' equity
Common stock
26.562
20.697
20.131
10.636
Retained earnings
-108,500
-71,801
-32,821
-9,587
Accumulated other comprehensive income
-10.321
-10.958
-
-
Total stockholders' equity
54,584
33,971
61,607
15,175
Total liabilities and stockholders' equity
71,605
45,363
66,954
16,279